Cargando…

TNFα inhibitors as targets for protective therapies in MSA: a viewpoint

Multiple system atrophy (MSA) is a unique and fatal α-synucleinopathy associated with oligodendroglial inclusions and secondary neurodegeneration affecting striatum, substantia nigra, pons, and cerebellum. The pathogenesis remains elusive; however, there is emerging evidence suggesting a prominent r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ndayisaba, Alain, Jellinger, Kurt, Berger, Thomas, Wenning, Gregor K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6458780/ https://www.ncbi.nlm.nih.gov/pubmed/30975183 http://dx.doi.org/10.1186/s12974-019-1477-5

Ejemplares similares

The Relevance of Iron in the Pathogenesis of Multiple System Atrophy: A Viewpoint
por: Kaindlstorfer, Christine, et al.
Publicado: (2018)

Targeted overexpression of human α-synuclein in oligodendroglia induces lesions linked to MSA -like progressive autonomic failure
por: Stemberger, Sylvia, et al.
Publicado: (2010)

Limited effects of dysfunctional macroautophagy on the accumulation of extracellularly derived α-synuclein in oligodendroglia: implications for MSA pathogenesis
por: Fellner, Lisa, et al.
Publicado: (2018)

Commentary: Discriminating α-synuclein strains in parkinson's disease and multiple system atrophy
por: Fellner, Lisa, et al.
Publicado: (2020)

Oligodendroglial alpha-synucleinopathy and MSA-like cardiovascular autonomic failure: Experimental evidence
por: Kuzdas, Daniela, et al.
Publicado: (2013)

Iron in Neurodegeneration – Cause or Consequence?
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Is Multiple System Atrophy a Prion-like Disorder?
por: Jellinger, Kurt A., et al.
Publicado: (2021)

Genetic Diversity of Babesia bovis MSA-1, MSA-2b and MSA-2c in China
por: Wang, Jinming, et al.
Publicado: (2020)

Induced pluripotent stem cells in multiple system atrophy: recent developments and scientific challenges
por: Ndayisaba, Alain, et al.
Publicado: (2019)

Multiple system atrophy as emerging template for accelerated drug discovery in α-synucleinopathies
por: Krismer, Florian, et al.
Publicado: (2014)

Towards translational therapies for multiple system atrophy
por: Kuzdas-Wood, Daniela, et al.
Publicado: (2014)

Targeting TNF-α for cancer therapy
por: Burton, Elizabeth R, et al.
Publicado: (2009)

A comparison of MSA tools
por: Essoussi, Nadia, et al.
Publicado: (2008)

Methotrexate as combination partner of TNF inhibitors and tocilizumab. What is reasonable from an immunological viewpoint?
por: Witte, Torsten
Publicado: (2015)

Perspectives for TNF-α-targeting therapies
por: Lorenz, Hanns-Martin, et al.
Publicado: (2002)

Transcriptomic differences in MSA clinical variants
por: Pérez-Soriano, Alexandra, et al.
Publicado: (2020)

Interaction between α-Synuclein and Other Proteins in Neurodegenerative Disorders
por: Jellinger, Kurt A.
Publicado: (2011)

Kicking butt with MIDP and MSA : creating great mobile applications
por: Knudsen, Jonathan
Publicado: (2008)

TNF-α inhibitors: are they carcinogenic?
por: Raval, Girindra, et al.
Publicado: (2010)

The intensity of joint pain in relation to changes in serum TNFα during therapy with anti-TNFα inhibitors
por: Sikorska, Dorota, et al.
Publicado: (2019)

The Role of msa in Staphylococcus aureus Biofilm Formation
por: Sambanthamoorthy, Karthik, et al.
Publicado: (2008)

Early autonomic and cognitive dysfunction in PD, DLB and MSA: blurring the boundaries between α-synucleinopathies
por: Palermo, Giovanni, et al.
Publicado: (2020)

Propagation of Pathological α-Synuclein from the Urogenital Tract to the Brain Initiates MSA-like Syndrome
por: Ding, Xuebing, et al.
Publicado: (2020)

Asymptomatic CNS demyelination related to TNF-α inhibitor therapy
por: Ali, Farwa, et al.
Publicado: (2016)

Msa1 and Msa2 Modulate G1-Specific Transcription to Promote G1 Arrest and the Transition to Quiescence in Budding Yeast
por: Miles, Shawna, et al.
Publicado: (2016)

Characterizing the Late Pleistocene MSA Lithic Technology of Sibudu, KwaZulu-Natal, South Africa
por: Will, Manuel, et al.
Publicado: (2014)

Structure and function predictions of the Msa protein in Staphylococcus aureus
por: Nagarajan, Vijayaraj, et al.
Publicado: (2007)

MSA1.2.1 - EMI Reference Releases
Publicado: (Octo)

MSA1.2.2 - EMI Reference Releases
por: Members of EMI collaboration
Publicado: (Apri)

MSA1.2.3 - EMI Reference Releases
por: Members of EMI collaboration
Publicado: (Apri)

MSA1.2.3 - EMI Reference Releases
Publicado: (Apri)

Alpha-synuclein mRNA expression in oligodendrocytes in MSA
por: Asi, Yasmine T, et al.
Publicado: (2014)

The Importance of Connection to Others in QoL in MSA and PSP
por: Wiblin, Louise, et al.
Publicado: (2017)

learnMSA: learning and aligning large protein families
por: Becker, Felix, et al.
Publicado: (2022)

Similar neuronal imprint and no cross-seeded fibrils in α-synuclein aggregates from MSA and Parkinson’s disease
por: Laferrière, Florent, et al.
Publicado: (2022)

Cardiovascular autonomic function testing in multiple system atrophy and Parkinson’s disease: an expert-based blinded evaluation
por: Leys, Fabian, et al.
Publicado: (2020)

A recombinant multi-antigen vaccine formulation containing Babesia bovis merozoite surface antigens MSA-2a(1), MSA-2b and MSA-2c elicits invasion-inhibitory antibodies and IFN-γ producing cells
por: Gimenez, Alba Marina, et al.
Publicado: (2016)

Discrimination of MSA-P and MSA-C by RT-QuIC analysis of olfactory mucosa: the first assessment of assay reproducibility between two specialized laboratories
por: Bargar, Connor, et al.
Publicado: (2021)

L-dopa response pattern in a rat model of mild striatonigral degeneration
por: Kaindlstorfer, Christine, et al.
Publicado: (2019)

mSA2 affinity-enhanced biotin-binding CAR T cells for universal tumor targeting
por: Lohmueller, Jason J., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_717hhssejbq1bl9fq2kcf8aa2u